Status:
COMPLETED
Kinetics of Metabolic Cofactors in NAFLD
Lead Sponsor:
Sahlgrenska University Hospital
Collaborating Sponsors:
Karolinska Institutet
Chalmers University of Technology
Conditions:
Healthy
Eligibility:
MALE
18-40 years
Phase:
EARLY_PHASE1
Brief Summary
There is a strong correlation between major adverse health consequences of obesity and development of non-alcoholic fatty liver disease (NAFLD). NAFLD is characterized by abnormal hepatic accumulation...
Detailed Description
In 10 healthy subjects with BMI \<30 kg/m2 the plasma concentrations of 4 natural compounds (nicotinamide riboside, L-carnitine, L-serine and N-acetylcystein) are measured by ultra-performance liquid ...
Eligibility Criteria
Inclusion
- Healthy without any medication, no smokers, no obesity
Exclusion
- Any known disease, obesity
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03838822
Start Date
September 1 2018
End Date
December 1 2018
Last Update
February 15 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hanns-Ulrich Marschall
Gothenburg, Sweden, 411 31
2
Sahlgrenska Academy
Gothenburg, Sweden